Kisspeptin / working resource
Primary source desk
Keep the original documents and the limits of their conclusions within reach.
Start with the product-specific question
Kisspeptin-10 versus kisspeptin-54
Reproductive and sexual neuroscience without conflating indications. What should I know about kisspeptin-10 versus kisspeptin-54?
Open the Kisspeptin library ↗In the women’s HSDD crossover trial,32 women completed both visits involving acute IV kisspeptin 54 or placebo and neuroimaging measurements.
Read the original record ↗
The original record comes first.
These are starting points for the Kisspeptin library. Read the source's exact question, product, population and date. A source can be authoritative for one claim and irrelevant to another.
Keep claims and sources together.
In the women’s HSDD crossover trial,32 women completed both visits involving acute IV kisspeptin 54 or placebo and neuroimaging measurements.
Supporting record ↗The women’s study found changes in sexual/attraction brain processing, rather than demonstrating a durable cure for HSDD.
Supporting record ↗In the men’s HSDD crossover trial,32 men completed both visits; acute IV kisspeptin 54 changed neural processing and some secondary physiological/behavioral measures.
Supporting record ↗The 2014 IVF study administered subcutaneous kisspeptin 54 to 53 women after controlled ovarian stimulation; mature eggs and subsequent pregnancies were observed.
Supporting record ↗These fields stay in this page until you leave or reload. No notes are saved or transmitted. Print a copy if you want to keep your work. Educational organization tools do not replace clinical advice.